Lymphocyte response in disease may be appropriate (activation of the immune system) or inappropriate (immune-mediated disease and lymphoproliferative malignancies).
To study the influence of a family history of cancer on survival, the researchers examined Swedish cancer Registry data on 6946 patients treated for HL between 1965 and 1995.
3
有696(15%)位患者在最初确诊淋巴瘤一年后患上第二种恶性肿瘤。
Second malignancies developed in 696 (15%) HL patients a year or more after the original diagnosis.
点击反馈